Early exposure (+scaling?) [Nonparametrics]

posted by Helmut Homepage – Vienna, Austria, 2012-01-20 13:56 (4157 d 02:57 ago) – Posting: # 7978
Views: 12,105

Dear Joshua!

❝ Thank you so much for your reply. I was actually referring to the USFDA. :-)

IMHO FDA never asked for tmax. If clinically relevant ‘early exposure’ should be assessed (Guidance 2003, [image] Section III.A.8.a.):

[…] the guidance re­com­mends use of partial AUC as an early exposure measure. We re­com­mend that the partial area be truncated at the population median of Tmax values for the re­fe­rence formulation. We also recommend that at least two quantifiable samples be collected be­fore the expected peak time to allow adequate estimation of the partial area.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,622 posts in 4,742 threads, 1,612 registered users;
29 visitors (0 registered, 29 guests [including 11 identified bots]).
Forum time: 17:53 CEST (Europe/Vienna)

Outside his own ever-narrowing field of specialization,
a scientist is a layman.
What members of an academy of science have in common
is a certain form of semiparasitic living.    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz